A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned

Availability of integrase strand transfer inhibitors created interest in determining whether their use would decrease persistently infected cell numbers. This study hypothesized that adding raltegravir (RAL) to standard antiretroviral therapy (ART) would decrease human immunodeficiency virus (HIV)-i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biores Open Access
Main Authors: Collier, Ann C., Chun, Tae-Wook, Maenza, Janine, Coombs, Robert W., Tapia, Kenneth, Chang, Ming, Stevens, Claire E., Justement, J. Shawn, Murray, Danielle, Stekler, Joanne D., Mullins, James I, Holte, Sarah E.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2016
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4744890/
https://ncbi.nlm.nih.gov/pubmed/26862469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/biores.2015.0038
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados